Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-14 6:57 pm Purchase | 13G | ADVERUM BIOTECHNOLOGIES INC CO ADVM | Vivo Opportunity Fund Holdings L.P. | 218,895 1.100% | 218,895 (New Position) | View |
| 2024-11-14 6:40 pm Purchase | 13G | ADVERUM BIOTECHNOLOGIES INC CO ADVM | Logos Global Management LP | 416,666 2.000% | 416,666 (New Position) | View |
| 2024-11-14 4:05 pm Unchanged | 13G | ADVERUM BIOTECHNOLOGIES INC CO ADVM | COMMODORE CAPITAL LP | 0 0.000% | 0 (Unchanged) | View |
| 2024-11-12 09:50 am Purchase | 13G | ADVERUM BIOTECHNOLOGIES INC CO ADVM | FMR LLC | 234,718 1.128% | 234,718 (New Position) | View |
| 2024-11-08 2:17 pm Unchanged | 13G | ADVERUM BIOTECHNOLOGIES INC CO ADVM | BlackRock Inc. | 1,490,709 7.200% | 0 (Unchanged) | View |
| 2024-11-06 5:49 pm Purchase | 13G | ADVERUM BIOTECHNOLOGIES INC CO ADVM | MORGAN STANLEY MS | 78,862 0.400% | 78,862 (New Position) | View |
| 2024-10-30 9:34 pm Purchase | 13G | ADVERUM BIOTECHNOLOGIES INC CO ADVM | Stern Augustus | 1,116,628 5.370% | 1,116,628 (New Position) | View |
| 2024-10-23 1:34 pm Purchase | 13G | ADVERUM BIOTECHNOLOGIES INC CO ADVM | Principia Wealth Advisory LLC | 1,055,103 5.070% | 1,055,103 (New Position) | View |
| 2024-10-22 6:06 pm Purchase | 13G | ADVERUM BIOTECHNOLOGIES INC CO ADVM | BlackRock Inc. | 1,490,709 7.200% | 1,490,709 (New Position) | View |
| 2024-07-22 4:24 pm Purchase | 13G | ADVERUM BIOTECHNOLOGIES INC CO ADVM | BML Investment Partners L.P. | 2,206,346 10.600% | 1,065,346 (+93.37%) | View |
| 2024-05-14 5:06 pm Sale | 13D | ADVERUM BIOTECHNOLOGIES INC CO ADVM | Versant Ventures IV LLC | 500,387 2.400% | -4,503,505 (-90.00%) | View |
| 2024-04-29 4:10 pm Sale | 13G | ADVERUM BIOTECHNOLOGIES INC CO ADVM | BML Investment Partners L.P. | 1,141,000 5.500% | -3,713,252 (-76.49%) | View |
| 2024-02-22 3:47 pm Purchase | 13G | ADVERUM BIOTECHNOLOGIES INC CO ADVM | Logos Global Management LP | 15,000,000 7.200% | 15,000,000 (New Position) | View |
| 2024-02-15 4:17 pm Purchase | 13G | ADVERUM BIOTECHNOLOGIES INC CO ADVM | TCG Crossover GP II LLC | 20,763,572 9.900% | 20,763,572 (New Position) | View |
| 2024-02-14 8:26 pm Purchase | 13G | ADVERUM BIOTECHNOLOGIES INC CO ADVM | Venrock Healthcare Capital Partners III L.P. | 15,564,213 7.500% | 9,664,724 (+163.82%) | View |
| 2024-02-14 4:30 pm Purchase | 13G | ADVERUM BIOTECHNOLOGIES INC CO ADVM | Vivo Opportunity Fund Holdings L.P. | 15,000,000 7.200% | 15,000,000 (New Position) | View |
| 2024-02-14 4:05 pm Purchase | 13G | ADVERUM BIOTECHNOLOGIES INC CO ADVM | COMMODORE CAPITAL LP | 10,000,000 9.900% | 3,841,859 (+62.39%) | View |
| 2024-02-13 7:34 pm Sale | 13G | ADVERUM BIOTECHNOLOGIES INC CO ADVM | BANK OF AMERICA CORP BAC | 4,425,895 4.400% | -1,166,001 (-20.85%) | View |
| 2024-02-12 10:13 am Sale | 13G | ADVERUM BIOTECHNOLOGIES INC CO ADVM | MORGAN STANLEY MS | 5,150,496 5.100% | -1,984,556 (-27.81%) | View |
| 2024-02-09 11:41 am Purchase | 13G | ADVERUM BIOTECHNOLOGIES INC CO ADVM | Frazier Life Sciences Public Fund L.P. | 10,416,666 11.000% | 10,416,666 (New Position) | View |